Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report
Published: December 2012 · Publisher: MarketLine
Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Celldex Therapeutics, Inc.
- Intelligence on Celldex Therapeutics, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Celldex Therapeutics (Celldex) is a development-stage biotechnology company. It is engaged in the discovery, development and commercialization of targeted immunotherapies. The company focuses on the use of tumor-specific targets and human monoclonal antibodies as precision delivered therapeutic agents for the treatment of cancer, infectious and inflammatory diseases. The company operates in the US and the UK. It is headquartered in Needham, Massachusetts and employed 94 people as of December 31, 2010. The company recorded revenues of $46.8 million during the financial year (FY) ended December 2010, compared to the revenues of $15.2 million in FY2009. The operating loss of the company was $6.5 million during FY2010, compared to an operating loss of $36.9 million in FY2009. The net loss was $2.5 million in FY2010, compared to a net loss of $36.5 million in FY2009.
Reasons to Purchase:
- Gain understanding of Celldex Therapeutics, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Celldex Therapeutics, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Celldex Therapeutics, Inc.’s business structure, strategy and prospects
Features:
- Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Celldex Therapeutics, Inc.
- Intelligence on Celldex Therapeutics, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Celldex Therapeutics (Celldex) is a development-stage biotechnology company. It is engaged in the discovery, development and commercialization of targeted immunotherapies. The company focuses on the use of tumor-specific targets and human monoclonal antibodies as precision delivered therapeutic agents for the treatment of cancer, infectious and inflammatory diseases. The company operates in the US and the UK. It is headquartered in Needham, Massachusetts and employed 94 people as of December 31, 2010. The company recorded revenues of $46.8 million during the financial year (FY) ended December 2010, compared to the revenues of $15.2 million in FY2009. The operating loss of the company was $6.5 million during FY2010, compared to an operating loss of $36.9 million in FY2009. The net loss was $2.5 million in FY2010, compared to a net loss of $36.5 million in FY2009.
Reasons to Purchase:
- Gain understanding of Celldex Therapeutics, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Celldex Therapeutics, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Celldex Therapeutics, Inc.’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Celldex Therapeutics, Inc.: Company Overview
Celldex Therapeutics, Inc.: Overview and Key Facts
Celldex Therapeutics, Inc.: Overview
Celldex Therapeutics, Inc.: Key Facts
Celldex Therapeutics, Inc.: Key Employees
Celldex Therapeutics, Inc.: Key Employee Biographies
Celldex Therapeutics, Inc.: Major Products and Services
Celldex Therapeutics, Inc.: Company History
Celldex Therapeutics, Inc.: Management Statement
Celldex Therapeutics, Inc.: Locations and Subsidiaries
Celldex Therapeutics, Inc.: Key Competitors
Celldex Therapeutics, Inc.: Company Analysis
Celldex Therapeutics, Inc.: Business Description
Celldex Therapeutics, Inc.: SWOT Analysis
Celldex Therapeutics, Inc.: SWOT Overview
Celldex Therapeutics, Inc.: Strengths
Celldex Therapeutics, Inc.: Weaknesses
Celldex Therapeutics, Inc.: Opportunities
Celldex Therapeutics, Inc.: Threats
Celldex Therapeutics, Inc.: Corporate Financial Deals Activity
Celldex Therapeutics, Inc.: Financial Deals Overview
Celldex Therapeutics, Inc.: Targets and Partners
Celldex Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Celldex Therapeutics, Inc.: Advisors
Celldex Therapeutics, Inc.: Top Legal Advisors
Celldex Therapeutics, Inc.: Top Financial Advisors
Celldex Therapeutics, Inc.: Mergers and Acquisitions
Celldex Therapeutics, Inc.: Capital Raising
Celldex Therapeutics, Inc.: Partnership
Celldex Therapeutics, Inc.: Divestments
Celldex Therapeutics, Inc.: Recent Developments
Celldex Therapeutics, Inc.: News and Events Summary
Celldex Therapeutics, Inc.: Contracts
Celldex Therapeutics, Inc.: Corporate Governance
Celldex Therapeutics, Inc.: Financial Deals
Celldex Therapeutics, Inc.: Financial Performance
Celldex Therapeutics, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Celldex Therapeutics, Inc.: Key Facts
Table 2: Celldex Therapeutics, Inc.: Key Employees
Table 4: Celldex Therapeutics, Inc.: Key Competitors
Table 5: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Celldex Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Celldex Therapeutics, Inc.: Targets and Partners
Table 9: Celldex Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Table 10: Celldex Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Celldex Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Celldex Therapeutics, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 13: Celldex Therapeutics, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 14: Celldex Therapeutics, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 15: Celldex Therapeutics, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 16: Celldex Therapeutics, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 17: Celldex Therapeutics, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 18: Celldex Therapeutics, Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 19: Celldex Therapeutics, Inc.: Divestments by Geography (2009 - YTD*2013)
Table 20: Celldex Therapeutics, Inc.: News and Events Summary
Table 21: Celldex Therapeutics, Inc.: Contracts
Table 22: Celldex Therapeutics, Inc.: Corporate Governance
Table 23: Celldex Therapeutics, Inc.: Financial Deals
Table 24: Celldex Therapeutics, Inc.: Financial Performance
Table 25: Celldex Therapeutics, Inc.: Research & Development
List of Figures
Figure 1: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 3: Celldex Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Celldex Therapeutics, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 5: Celldex Therapeutics, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 6: Celldex Therapeutics, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 7: Celldex Therapeutics, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 8: Celldex Therapeutics, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 9: Celldex Therapeutics, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 10: Celldex Therapeutics, Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 11: Celldex Therapeutics, Inc.: Divestments by Geography (2009 - YTD*2013)
Celldex Therapeutics, Inc.: Company Overview
Celldex Therapeutics, Inc.: Overview and Key Facts
Celldex Therapeutics, Inc.: Overview
Celldex Therapeutics, Inc.: Key Facts
Celldex Therapeutics, Inc.: Key Employees
Celldex Therapeutics, Inc.: Key Employee Biographies
Celldex Therapeutics, Inc.: Major Products and Services
Celldex Therapeutics, Inc.: Company History
Celldex Therapeutics, Inc.: Management Statement
Celldex Therapeutics, Inc.: Locations and Subsidiaries
Celldex Therapeutics, Inc.: Key Competitors
Celldex Therapeutics, Inc.: Company Analysis
Celldex Therapeutics, Inc.: Business Description
Celldex Therapeutics, Inc.: SWOT Analysis
Celldex Therapeutics, Inc.: SWOT Overview
Celldex Therapeutics, Inc.: Strengths
Celldex Therapeutics, Inc.: Weaknesses
Celldex Therapeutics, Inc.: Opportunities
Celldex Therapeutics, Inc.: Threats
Celldex Therapeutics, Inc.: Corporate Financial Deals Activity
Celldex Therapeutics, Inc.: Financial Deals Overview
Celldex Therapeutics, Inc.: Targets and Partners
Celldex Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Celldex Therapeutics, Inc.: Advisors
Celldex Therapeutics, Inc.: Top Legal Advisors
Celldex Therapeutics, Inc.: Top Financial Advisors
Celldex Therapeutics, Inc.: Mergers and Acquisitions
Celldex Therapeutics, Inc.: Capital Raising
Celldex Therapeutics, Inc.: Partnership
Celldex Therapeutics, Inc.: Divestments
Celldex Therapeutics, Inc.: Recent Developments
Celldex Therapeutics, Inc.: News and Events Summary
Celldex Therapeutics, Inc.: Contracts
Celldex Therapeutics, Inc.: Corporate Governance
Celldex Therapeutics, Inc.: Financial Deals
Celldex Therapeutics, Inc.: Financial Performance
Celldex Therapeutics, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Celldex Therapeutics, Inc.: Key Facts
Table 2: Celldex Therapeutics, Inc.: Key Employees
Table 4: Celldex Therapeutics, Inc.: Key Competitors
Table 5: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Celldex Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Celldex Therapeutics, Inc.: Targets and Partners
Table 9: Celldex Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Table 10: Celldex Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Celldex Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Celldex Therapeutics, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 13: Celldex Therapeutics, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 14: Celldex Therapeutics, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 15: Celldex Therapeutics, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 16: Celldex Therapeutics, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 17: Celldex Therapeutics, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 18: Celldex Therapeutics, Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 19: Celldex Therapeutics, Inc.: Divestments by Geography (2009 - YTD*2013)
Table 20: Celldex Therapeutics, Inc.: News and Events Summary
Table 21: Celldex Therapeutics, Inc.: Contracts
Table 22: Celldex Therapeutics, Inc.: Corporate Governance
Table 23: Celldex Therapeutics, Inc.: Financial Deals
Table 24: Celldex Therapeutics, Inc.: Financial Performance
Table 25: Celldex Therapeutics, Inc.: Research & Development
List of Figures
Figure 1: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 3: Celldex Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Celldex Therapeutics, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 5: Celldex Therapeutics, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 6: Celldex Therapeutics, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 7: Celldex Therapeutics, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 8: Celldex Therapeutics, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 9: Celldex Therapeutics, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 10: Celldex Therapeutics, Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 11: Celldex Therapeutics, Inc.: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.